Stay updated on Apalutamide Study in High-Risk Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Apalutamide Study in High-Risk Prostate Cancer Clinical Trial page.

Latest updates to the Apalutamide Study in High-Risk Prostate Cancer Clinical Trial page
- Check2 days agoChange DetectedA sitewide NIH banner announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to related updates and FAQs.SummaryDifference0.2%

- Check9 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.0%

- Check16 days agoChange DetectedThe site footer revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check30 days agoChange DetectedNew history entries add updated Study Status and Contacts/Locations for the trial, with changes dated 2026-09-24 and 2026-09-25. An entry dated 2026-08-28 has been removed.SummaryDifference0.2%

- Check37 days agoChange DetectedA new system revision entry v3.7.0 was added to the record history, replacing the previous revision v3.6.6.SummaryDifference0.0%

- Check58 days agoChange DetectedA new revision entry (v3.6.6) is added to the record history on 2026-08-28, including updates to Study Status and Contacts/Locations, while the prior revision (v3.6.5) was removed on 2026-07-31.SummaryDifference0.2%

Stay in the know with updates to Apalutamide Study in High-Risk Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Apalutamide Study in High-Risk Prostate Cancer Clinical Trial page.